Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × binimetinib × Clear all

Sponsor

Conditions

Melanoma 12 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Neoplasms 4 Lung Neoplasms 4 Brain Neoplasms 4 Skin Neoplasms 2 Skin Diseases 2 Hematologic Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Soft Tissue Neoplasms 1 Peripheral Nervous System Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Noonan Syndrome 5 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Multiple Myeloma 1 Lymphoma 1 Lymphatic Metastasis 1 Low-grade Serous Ovarian Cancer 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Gliosarcoma 1

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡